Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
| Conditions: | Mesothelioma, Non-Small-Cell Lung Carcinoma |
| Start Date: | August 1, 2005 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00106626 |
| Study Type: | Interventional |
| Intervention: | Drug: Suberoylanilide Hydroxamic Acid (SAHA) |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
| Results: | No Results Available |
| Sponsors: | Merck |
| Ages: | Adult, Senior |
| Enrollment: | 52 |
| Funded By: | INDUSTRY |
| First Received: | March 28, 2005 |
| End Date: | December 1, 2007 |
| Last Updated: | November 13, 2008 |
| Last Verified: | November 1, 2008 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
